146 related articles for article (PubMed ID: 36301568)
1. Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
Rettig EM; Wang AA; Tran NA; Carey E; Dey T; Schoenfeld JD; Sehgal K; Guenette JP; Margalit DN; Sethi R; Uppaluri R; Tishler RB; Annino DJ; Goguen LA; Jo VY; Haddad RI; Hanna GJ
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1120-1130. PubMed ID: 36301568
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
3. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract][Full Text] [Related]
5. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
Berger BM; Hanna GJ; Posner MR; Genden EM; Lautersztain J; Naber SP; Del Vecchio Fitz C; Kuperwasser C
Clin Cancer Res; 2022 Oct; 28(19):4292-4301. PubMed ID: 35576437
[TBL] [Abstract][Full Text] [Related]
6. Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
Hanna GJ; Roof SA; Jabalee J; Rettig EM; Ferrandino R; Chen S; Posner MR; Misiukiewicz KJ; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Gupta P; Kuperwasser C; Del Vecchio Fitz C; Berger BM
Clin Cancer Res; 2023 Oct; 29(20):4306-4313. PubMed ID: 37566241
[TBL] [Abstract][Full Text] [Related]
7. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
Rettig EM; Faden DL; Sandhu S; Wong K; Faquin WC; Warinner C; Stephens P; Kumar S; Kuperwasser C; Richmon JD; Uppaluri R; Varvares M; Sethi R; Hanna GJ; Sroussi H
Int J Cancer; 2022 Oct; 151(7):1081-1085. PubMed ID: 35262203
[TBL] [Abstract][Full Text] [Related]
9. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
[No Abstract] [Full Text] [Related]
11. Liquid Biopsies with Circulating Plasma HPV-DNA Measurements-A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer.
Jakobsen KK; Bendtsen SK; Pallisgaard N; Friborg J; Lelkaitis G; Grønhøj C; von Buchwald C
Clin Cancer Res; 2023 Oct; 29(19):3914-3923. PubMed ID: 37477909
[TBL] [Abstract][Full Text] [Related]
12. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
[TBL] [Abstract][Full Text] [Related]
13. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
[TBL] [Abstract][Full Text] [Related]
14. The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: A simulation.
Ward MC; Miller JA; Walker GV; Moeller BJ; Koyfman SA; Shah C
Oral Oncol; 2022 Mar; 126():105721. PubMed ID: 35077916
[TBL] [Abstract][Full Text] [Related]
15. Association of Smoking, Comorbidity, Clinical Stage, and Treatment Intent With Socioeconomic Differences in Survival After Oropharyngeal Squamous Cell Carcinoma in Denmark.
Olsen MH; Frederiksen K; Lassen P; Rotbøl C; Kjaer TK; Johansen J; Primdahl H; Andersen E; Kristensen CA; Andersen M; Farhadi M; Overgaard J; Dalton SO;
JAMA Netw Open; 2022 Dec; 5(12):e2245510. PubMed ID: 36477477
[TBL] [Abstract][Full Text] [Related]
16. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review.
Lang Kuhs KA; Brenner JC; Holsinger FC; Rettig EM
JAMA Oncol; 2023 Dec; 9(12):1716-1724. PubMed ID: 37824111
[TBL] [Abstract][Full Text] [Related]
18. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
[TBL] [Abstract][Full Text] [Related]
20. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
